Using a machine learning model to risk stratify for the presence of significant liver disease in a primary care population (2023)
Attributed to:
Interrogating ITGA11 signalling in rodent and human for targeted anti-fibrotic therapy in liver fibrosis.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.21037/jmai-23-35
Publication URI: http://dx.doi.org/10.21037/jmai-23-35
Type: Journal Article/Review
Parent Publication: Journal of Medical Artificial Intelligence